Your browser doesn't support javascript.
loading
Personality Dimensions Are Associated with Quality of Life in Fluctuating Parkinson's Disease Patients (PSYCHO-STIM).
Boussac, Mathilde; Arbus, Christophe; Dupouy, Julia; Harroch, Estelle; Rousseau, Vanessa; Ory-Magne, Fabienne; Rascol, Olivier; Moreau, Caroline; Maltête, David; Rouaud, Tiphaine; Meyer, Mylène; Houvenaghel, Jean Francois; Marsé, Claire; Tranchant, Christine; Hainque, Elodie; Jarraya, Béchir; Ansquer, Solène; Bonnet, Marie; Belamri, Lhaouas; Tir, Mélissa; Marques, Ana-Raquel; Danaila, Teodor; Eusebio, Alexandre; Devos, David; Brefel-Courbon, Christine.
Afiliación
  • Boussac M; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, Toulouse, France.
  • Arbus C; Psychiatry Department of the University Hospital of Toulouse, CHU Purpan, Toulouse, France.
  • Dupouy J; Department of Clinical Pharmacology and Neurosciences, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, Toulouse, France.
  • Harroch E; Department of Clinical Pharmacology and Neurosciences, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, Toulouse, France.
  • Rousseau V; Department of Clinical Pharmacology and Neurosciences, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, Toulouse, France.
  • Ory-Magne F; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, Toulouse, France.
  • Rascol O; Psychiatry Department of the University Hospital of Toulouse, CHU Purpan, Toulouse, France.
  • Moreau C; Department of Clinical Pharmacology and Neurosciences, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, Toulouse, France.
  • Maltête D; Department of Clinical Pharmacology and Neurosciences, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, Toulouse, France.
  • Rouaud T; CHU of Lille, Univ. Lille, Inserm UMRS_1171, Licend, Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent Center of Parkinson's Disease, Lille, France.
  • Meyer M; Department of Neurology, Rouen University Hospital and University of Rouen, France; INSERM U1239, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan, France.
  • Houvenaghel JF; Clinique Neurologique, Hôpital Guillaume et René Laennec, Boulevard Jacques Monod, Nantes Cedex.
  • Marsé C; Neurology Department, Nancy University Hospital, Nancy, France.
  • Tranchant C; Behavior and Basal Ganglia" Research Unit (EA 4712), University of Rennes 1, Rennes, France; Department of Neurology, Rennes University Hospital, Rennes Cedex, France.
  • Hainque E; CHU Nice, Centre Expert Parkinson, Service de Neurologie, Nice, France.
  • Jarraya B; Service de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM-U964/CNRS-UMR7104/Université de Strasbourg, Illkirch, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de S
  • Ansquer S; Département de Neurologie, Hôpital Pitié-Salpêtrière, AP-HP, Faculté de Médecine de Sorbonne Université, UMR S 1127, Inserm U 1127, and CNRS UMR 7225, and Institut du Cerveau et de la Moëlle épinière, Paris, France.
  • Bonnet M; Pôle Neurosciences, Foch Hospital, Suresnes, France; Université de Versailles Paris-Saclay, INSERM U992, CEA Neurospin, Paris, France.
  • Belamri L; Service de Neurologie, Centre Expert Parkinson, CIC-INSERM 1402, CHU Poitiers, Poitiers, France.
  • Tir M; CHU de Bordeaux, Centre Expert Parkinson, Institut des maladies neuro-dégénératives, Bordeaux, France.
  • Marques AR; Hôpital Fondation A de Rothschild, service de recherche clinique, F-75019 Paris, France.
  • Danaila T; Department of Neurology, Department of Neurosurgery, Expert Centre for Parkinson's Disease, Amiens University Hospital, EA 4559 Laboratoire de Neurosciences Fonctionnelles et Pathologie (LNFP) Université de Picardie Jules Verne, University of Picardy Jules Verne (UPJV), Amiens, France.
  • Eusebio A; Université Clermont Auvergne, EA7280, Clermont-Ferrand University Hospital, Neurology Department, Clermont-Ferrand, France.
  • Devos D; Centre Expert Parkinson, Hôpital Neurologique "Pierre Wertheimer", Hospices Civils de Lyon, Bron, France.
  • Brefel-Courbon C; Aix Marseille Université, AP-HM, Hôpital de La Timone, Service de Neurologie et Pathologie du Mouvement, and UMR CNRS 7289, Institut de Neuroscience de La Timone, Marseille, France.
J Parkinsons Dis ; 10(3): 1057-1066, 2020.
Article en En | MEDLINE | ID: mdl-32444557
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Calidad de Vida / Temperamento / Carácter Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Parkinsons Dis Año: 2020 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Calidad de Vida / Temperamento / Carácter Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Parkinsons Dis Año: 2020 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Países Bajos